Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10533550 | 0.93 | DNM1 (0.71) | DNM1ALDH1A1TSHRCA2FDPS | |
| SCHEMBL25220984 | 0.90 | DNM1 (0.67) | DNM1ALDH1A1TSHRCA2FDPS | |
| SCHEMBL2316860 | 0.90 | DNM1 (0.46) | DNM1ALDH1A1TSHRCA2SMN1; SMN2 | |
| SCHEMBL7558646 | 0.90 | DNM1 (0.67) | DNM1ALDH1A1TSHRCA2FDPS | |
| SCHEMBL13277882 | 0.90 | DNM1 (0.67) | DNM1ALDH1A1TSHRCA2FDPS | |
| SCHEMBL8193369 | 0.82 | TSHR (0.42) | DNM1ALDH1A1TSHR | |
| SCHEMBL2864120 | 0.82 | DNM1 (0.71) | DNM1ALDH1A1TSHRCA2SMN1; SMN2 | |
| SCHEMBL29496398 | 0.82 | DNM1 (0.80) | DNM1ALDH1A1TSHRCA2SMN1; SMN2 | |
| SCHEMBL31751925 | 0.81 | ALDH1A1 (0.46) | DNM1ALDH1A1TSHRCA2SMN1; SMN2 | |
| SCHEMBL11387595 | 0.80 | DNM1 (0.54) | DNM1ALDH1A1TSHRCA2FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612702-B2 | Electrochemical oxidation of cycloalkenes to form alpha, omega-dicarboxylic acids and ketocarboxylic acids | EVONIK OPERATIONS GMBH (DE) | 2026-04-28 | — | — | US | claimed |
| US-12601067-B2 | Electrochemical oxidation of cycloalkenes and cycloalkanes into α,ω-dicarboxylic acids or into ketocarboxylic acids and cycloalkanone compounds | EVONIK OPERATIONS GMBH (DE) | 2026-04-14 | — | — | US | claimed |
| US-12577688-B2 | Electrochemical oxidation of fatty acids and fatty acid esters to form monocarboxylic acids and alpha-omega-dicarboxylic acids | EVONIK OPERATIONS GMBH (DE) | 2026-03-17 | — | — | US | claimed |
| US-12571114-B2 | Electrochemical oxidation of cycloalkanes to form cycloalkanone compounds | EVONIK OPERATIONS GMBH (DE) | 2026-03-10 | — | — | US | claimed |
| US-20250223709-A1 | ELECTROCHEMICAL OXIDATION OF FATTY ACIDS AND FATTY ACID ESTERS TO FORM MONOCARBOXYLIC ACIDS AND ALPHA-OMEGA-DICARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2025-07-10 | — | — | US | claimed |
| US-20250215583-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKANES TO FORM CYCLOALKANONE COMPOUNDS | EVONIK OPERATIONS GMBH (DE) | 2025-07-03 | — | — | US | claimed |
| US-20250215584-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKENES TO FORM ALPHA, OMEGA -DICARBOXYLIC ACIDS AND KETOCARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2025-07-03 | — | — | US | claimed |
| US-20250109509-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKENES AND CYCLOALKANES INTO a,w-DICARBOXYLIC ACIDS OR INTO KETOCARBOXYLIC ACIDS AND CYCLOALKANONE COMPOUNDS | EVONIK OPERATIONS GMBH (DE) | 2025-04-03 | — | — | US | claimed |
| EP-4499898-A1 | ELECTROCHEMICAL OXIDATION OF FATTY ACIDS AND FATTY ACID ESTERS TO FORM MONOCARBOXYLIC ACIDS AND ALPHA-OMEGA-DICARBOXYLIC ACIDS | Evonik Operations GmbH (DE) | 2025-02-05 | — | — | EP | claimed |
| EP-4499899-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKENES AND CYCLOALKANES INTO a,w-DICARBOXYLIC ACIDS OR INTO KETOCARBOXYLIC ACIDS AND CYCLOALKANONE COMPOUNDS | Evonik Operations GmbH (DE) | 2025-02-05 | — | — | EP | claimed |
| CN-118974325-A | Electrochemical oxidation of cycloolefins to form alpha, omega-dicarboxylic acids and ketocarboxylic acids | 赢创运营有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118974324-A | Electrochemical oxidation of cycloalkanes to cycloalkanone compounds | 赢创运营有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118946687-A | Electrochemical oxidation of fatty acids and fatty acid esters to form monocarboxylic acids and alpha-omega-dicarboxylic acids | 赢创运营有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118946686-A | Electrochemical oxidation of cycloolefins and cycloalkanes to alpha, omega-dicarboxylic acids or to ketocarboxylic acids and cycloalkanone compounds | 赢创运营有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118874550-A | Catalyst and method for preparing trifluoro chloroethylene and chloroethylene | 西安近代化学研究所 | 2024-11-01 | — | — | CN | claimed |
| WO-2023186660-A1 | ELECTROCHEMICAL OXIDATION OF FATTY ACIDS AND FATTY ACID ESTERS TO FORM MONOCARBOXYLIC ACIDS AND ALPHA-OMEGA-DICARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2023-10-05 | — | — | WO | claimed |
| WO-2023186658-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKENES TO FORM α, ω-DICARBOXYLIC ACIDS AND KETOCARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2023-10-05 | — | — | WO | claimed |
| WO-2023186661-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKENES AND CYCLOALKANES INTO α,ω-DICARBOXYLIC ACIDS OR INTO KETOCARBOXYLIC ACIDS AND CYCLOALKANONE COMPOUNDS | EVONIK OPERATIONS GMBH (DE) | 2023-10-05 | — | — | WO | claimed |
| WO-2023186659-A1 | ELECTROCHEMICAL OXIDATION OF CYCLOALKANES TO FORM CYCLOALKANONE COMPOUNDS | EVONIK OPERATIONS GMBH (DE) | 2023-10-05 | — | — | WO | claimed |
| US-4705897-A | Process for producing bicyclic diamines | TEXACO INC. (US) | 1987-11-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612702-B2 | Electrochemical oxidation of cycloalkenes to form alpha, omega-dicarboxylic acids and ketocarboxylic acids | ELOVL3, ALOX12, ELOVL1 | DNM1 2833/4885ALDH1A1 1377/4885TSHR 2570/4885 |
| US-12577688-B2 | Electrochemical oxidation of fatty acids and fatty acid esters to form monocarboxylic acids and alpha-omega-dicarboxylic acids | ELOVL1, ELOVL3, FFAR1 | DNM1 906/4885ALDH1A1 530/4885TSHR 2172/4885 |
| US-12571114-B2 | Electrochemical oxidation of cycloalkanes to form cycloalkanone compounds | CYP11B2, HCN3, CYBB | DNM1 2141/4885ALDH1A1 3589/4885TSHR 1602/4885 |
| US-12601067-B2 | Electrochemical oxidation of cycloalkenes and cycloalkanes into α,ω-dicarboxylic acids or into ketocarboxylic acids and cycloalkanone compounds | ALOX12, ELOVL1, ALOX15 | DNM1 1527/4885ALDH1A1 1341/4885TSHR 2109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.